Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abandonment, Accredo, adapt, affirmative, AG, age, alcohol, Aliz, allegedly, amino, aminoglycoside, Amneal, antibiotic, antibody, anticompetitive, appellate, ASP, asparaginase, Asparec, aspect, assay, ASU, ATRA, attend, audience, auditor, austerity, bacterium, BCA, Big, biosimilar, Biotest, BLA, blend, block, BPCIA, breakdown, breakout, breakthrough, breathing, bribery, British, brochure, burden, Burlington, Caphosol, capped, capromab, carbidopa, cardiovascular, Castle, casualty, catherine, cessation, chain, chargeback, cheaper, chemotherapy, childhood, chorea, chronotherapeutic, chrysanthemi, Circ, Citizen, clarified, CND, Coast, CODM, coli, collagen, Collatamp, compassionate, compel, compelling, condemnation, confidence, Connaught, constitutionality, construing, contamination, contractor, contraindication, Convention, conversion, core, Corrupt, Cove, creation, crucial, CSA, cure, currency, Custodiol, de, decentralized, declaratory, deploy, deployment, deprive, deprived, depriving, developmental, devise, digestive, discovered, distract, diversification, divested, divestiture, division, Durbin, dynamically, efficient, efficiently, eleven, environment, enzyme, Erwinase, Erwinaze, Erwinia, Escherichia, Essex, ETASU, ethylene, EU, Eurozone, EUSA, evidenced, evolving, exceptionally, excise, fact, falsified, fashion, FCP, FCPA, feasible, fifty, finite, Fintan, floor, footprint, forecast, forecasted, formation, formatting, France, French, FSS, FTC, fungal, FY, GBP, gentamicin, Germany, glycol, graft, grown, guarantor, Guard, headquartered, heard, heavily, heightened, Hooper, host, house, HPA, HRSA, HTK, Huntington, hypercholesterolaemia, hypersensitive, hypersensitivity, hypnogogic, hypothermic, imaging, immunologically, impregnated, improperly, impurity, indefinitely, inferred, infrastructure, injured, inolimomab, insert, insolvency, instability, internationally, intervention, intramuscular, Iranian, Japan, Jewel, John, justify, Keegan, kidney, Kidrolase, Kingdom, KPMG, Langhorne, legacy, lending, lengthened, Leukaemic, leukemia, leukemic, Leukotac, levodopa, lexidronam, liaison, LIBOR, lifecycle, lifted, liver, lump, lymphoblastic, lymphoma, Lyon, lyophilized, maker, mandatory, manifesting, Mayflower, Meda, MEPH, Mexico, microbially, Ministry, misleading, mission, mix, monoclonal, Morton, movement, NAVIGATOR, official, OPi, outbreak, outreach, outweigh, overcharge, overhead, oversee, Oxford, paediatric, passage, PCAOB, pegylated, penalized, pendetide, petition, pH, pharmacovigilance, phosphate, pilot, pipeline, platform, poisoning, pose, postural, Pound, poverty, pre, privacy, procedure, ProgramTM, promising, ProstaScint, prostate, prudent, psychology, Psychotropic, Pub, Quadramet, radiation, radiopharmaceutical, raw, reaction, ready, reallocate, recipient, recombinant, redeem, redeemable, reexamination, refilled, remeasured, repricing, reschedule, rescheduled, rescind, respiratory, rest, retrospective, revoked, rinse, rinsing, Road, Ronan, route, routinely, salary, samarium, SAS, Sawochka, segregated, sensitivity, sequestration, shaped, signatory, silent, sm, snail, Society, sohn, sovereign, speak, speech, statutorily, strain, stricter, strictly, struck, sublease, subsection, Sunshine, supersaturated, Supreme, Surrender, survey, Suzanne, swing, switching, talented, taxation, tentative, tetrabenazine, Threat, timeframe, TMA, Topic, traced, Tramadol, transformational, translate, translated, translation, transpire, transplantation, trillion, truthful, UK, uncovered, underway, undistributed, unfavorable, unremitted, upper, USPTO, VA, vacate, Versacloz, VersaclozTM, VHCA, viability, violative, vision, vital, vitro, vivo, winding, workforce, worth, Xenazine
Removed:
alan, alternate, analyzing, announced, asserted, BB, bore, Cephalon, certificate, children, clarification, commencement, commercialized, complicated, comprise, compromise, concomitant, confirmed, consumed, contact, contacting, cressey, depressive, detention, documented, entail, escalation, establishment, evaluated, exacerbation, exercisable, forced, harmful, improved, inception, incremental, informed, inspect, invoiced, JPI, judicially, led, Lonza, minimal, moderate, modification, partner, pattern, pivotal, Porter, preferable, qualification, recognizable, reject, reliably, removed, renewable, Revision, robert, sebulsky, separable, stimulant, structured, subcommittee, theInternational, tracked, undelivered, withdraw
Filing tables
Filing exhibits
- 10-K Annual report
- 10.13 Surrender of Lease
- 10.27 Us Rsu Notice & Agreement - 2007 Eip
- 10.28 Non-us Option Notice & Agreement - 2011 Eip
- 10.27 Us Option Notice & Agreement - 2007 Eip
- 10.27 Irish Option Notice & Agreement - 2007 Eip
- 10.27 Irish Rsu Notice & Agreement - 2007 Eip
- 10.28 Non-us Rsu Notice & Agreement - 2011 Eip
- 10.30 Non-us Option Notice & Agreement - 2007 Nesop
- 10.31 2007 Employee Stock Purchase Plan
- 10.32 Cash Bonus Plan - Us Affiliates
- 10.32 Cash Bonus Plan - International Affiliates 2003
- 21.1 Subsidiaries
- 23.1 Consent of KPMG, Independent Registered Public Accounting Firm
- 23.2 Consent of Ernst & Young, LLP, Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certifications of CEO and CFO Pursuant to 18 U.s.c. Section 1350
Related press release
JAZZ similar filings
Filing view
External links
Exhibit 23.1
Consent of KPMG, Independent Registered Public Accounting Firm
The Board of Directors
Jazz Pharmaceuticals plc
We consent to the incorporation by reference in the registration statement (No. 333‑179075) on Form S-8, and the registration statement (No. 333‑179080) on Form S-3, of Jazz Pharmaceuticals plc of our reports dated February 26, 2013, with respect to the consolidated balance sheet of Jazz Pharmaceuticals plc as of December 31, 2012, and the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for the year then ended, and the related financial statement schedule for the year ended December 31, 2012, and the effectiveness of internal control over financial reporting as of December 31, 2012, which reports appear in the December 31, 2012 annual report on Form 10‑K of Jazz Pharmaceuticals plc.
/s/ KPMG
Dublin, Ireland
February 26, 2013